(19)
(11) EP 1 324 759 A2

(12)

(88) Date of publication A3:
27.06.2002

(43) Date of publication:
09.07.2003 Bulletin 2003/28

(21) Application number: 01979731.5

(22) Date of filing: 12.10.2001
(51) International Patent Classification (IPC)7A61K 31/38
(86) International application number:
PCT/US0131/866
(87) International publication number:
WO 0203/0353 (18.04.2002 Gazette 2002/16)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 12.10.2000 US 239759 P

(71) Applicant: SmithKline Beecham Corporation
Philadelphia, PA 19103 (US)

(72) Inventors:
  • CALLAHAN, James, F.
    Collegeville, PA 19426 (US)
  • ROSHAK, AMY, K.
    King of Prussia, PA 19406 (US)

(74) Representative: Shore, Andrew David et al
GlaxoSmithKline,(CN 925.1),980 Great West Road
Brentford,Middlesex TW8 9GS
Brentford,Middlesex TW8 9GS (GB)

   


(54) NF-G(K)B INHIBITORS